• About us
• Contact

Advertisement

Organisation › Details

Merck & Co. Inc. (NYSE: MRK)

Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The Company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service *

 

	Start	1990-01-01 existent
	Group	Merck (US) (MSD) (Group)
	Industry	pharmaceutical
	Street	One Merck Drive P.O. Box 100
	City	08889-0100 Whitehouse Station, NJ
		Address record changed: 2020-12-02
Basic data	Employees	I: 50,001 to 100,0 (2007-11-13)
	Currency	USD
	Annual sales	22,600,000,000 (sales (2006) 2006-12-31)
	Profit	4,433,800,000 (2006-12-31)
		* Document for »About Section«:
		Record changed: 2024-04-27

Advertisement

More documents for Merck (US) (MSD) (Group)

• [1] Merck & Co., Inc.. (11/21/23). "Press Release: Merck to Acquire Caraway Therapeutics, Inc.". Rahway, NJ & Cambridge, MA....
• [2] AiCuris Anti-infective Cures AG. (8/23/23). "Press Release: AiCuris Received 30 Million Euros Milestone Payment from Licensing Partner MSD Following U.S. FDA Approval of Prevymis (letermovir) in Second Indication". Wuppertal....
• [3] Anavo Therapeutics B.V.. (5/2/23). "Press Release: Anavo Therapeutics Extends Seed Round to EUR 28 Million to Advance Pipeline of Novel Phosphatase Modulators Toward the Clinic". Leiden & Heidelberg....
• [4] Proxygen GmbH. (4/5/23). "Press Release: Proxygen Announces Collaboration and License Agreement with MSD". Vienna....
• [5] Novartis AG. (9/1/22). "Press Release: Novartis Appoints Fiona Marshall, Ph.D., President of the Novartis Institutes for BioMedical Research as Jay Bradner, M.D., Steps Down from the Executive Committee of Novartis". Basel....
• [6] Catalym GmbH. (5/4/21). "Press Release: Catalym Appoints Industry Leader Dr. Phil L’Huillier as Chief Executive Officer". Munich....
• [7] F2G Ltd.. (4/12/21). "Press Release: Francesco Maria Lavino Appointed Chief Executive Officer of F2G Ltd". Manchester & Vienna....
• [8] CRISPR Therapeutics AG. (2/1/21). "Press Release: CRISPR Therapeutics Announces the Appointment of Philippe Drouet as Chief Commercial Officer". Zug & Cambridge, MA....
• [9] Biognosys AG. (6/17/20). "Press Release: Biognosys Announces Appointment of Dr. Patrick Vink as Chairman". Schlieren....
• [10] Merck & Co., Inc.. (5/26/20). "Press Release: Merck to Acquire Themis". Kenilworth, NJ....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.